首页> 外文期刊>Cardiology clinics >Randomized Clinical Trials of Catheter Ablation of Atrial Fibrillation in Congestive Heart Failure Knowns and Unmet Needs
【24h】

Randomized Clinical Trials of Catheter Ablation of Atrial Fibrillation in Congestive Heart Failure Knowns and Unmet Needs

机译:用于充血性心力衰竭中的心房颤动导管消融的随机临床试验,已知和未满足需求

获取原文
获取原文并翻译 | 示例
       

摘要

Atrial fibrillation (AF) and heart failure (HF) are conditions that frequently coexist and are associated with worse outcomes compared with either condition alone. Although rhythm control with antiarrhythmic drug treatment is not superior to rate control in this population, catheter ablation has emerged as an alternative and more effective treatment of maintenance of sinus rhythm. Some trials have shown benefit in hospitalization and mortality, but additional studies are needed. The authors summarize the current evidence regarding catheter ablation outcomes, efficacy, and safety and discuss the unmet needs of the existing and ongoing randomized clinical trials.
机译:心房颤动(AF)和心力衰竭(HF)是经常共存的条件,与单独的任一种条件相比,与较差的结果相关。 虽然具有抗真菌药物治疗的节奏控制在该群群中不优于速率控制,但导管消融已成为欧洲节奏维持的替代方案和更有效的治疗方法。 一些试验表明,在住院治疗和死亡率的益处,但需要额外的研究。 作者总结了关于导管消融结果,疗效和安全的现有证据,并讨论了现有和正在进行的随机临床试验的未满足需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号